1.山东大学药学院免疫药物学研究所,济南 250012;2.齐鲁工业大学(山东省科学院)山东省分析测试中心环境与健康免疫研究室,济南 250014
山东省自然科学基金博士基金(ZR2017BH029)和山东省重点研发计划(2017GSF18159)资助项目
Institute of Immunopharmaceutical Sciences,School of Pharmaceutical Sciences,Shandong University
This work was supported by grants from the Shandong Provincial Natural Science Foundation, China (ZR2017BH029) and Shandong Provincial Key Research and Development Program (2017GSF18159)
肿瘤细胞能够通过多种机制抵御免疫防御或药物的抗肿瘤作用. 近年研究发现,外泌体能够直接介导癌症的进展和远端转移灶的形成. 更为重要的是,在肿瘤免疫微环境中,肿瘤来源外泌体不仅能够抑制树突状细胞(DC)、巨噬细胞、T细胞、NK细胞等免疫细胞功能,还能促进骨髓来源的抑制性细胞(MDSC)、调节性T细胞(Treg)等的免疫抑制功能,进而降低抗肿瘤免疫应答过程,帮助肿瘤细胞逃避机体免疫细胞识别. 本文将概述肿瘤外泌体及其携带的关键介质分子在介导肿瘤免疫逃逸和耐受过程中扮演的角色,并对这一研究领域的最新进展作一综述.
Tumor cells can derive a variety of mechanisms to resist immune defense or drug action. Recent studies have demonstrated that exosomes can mediate cancer progression and distal metastasis. Importantly, exosome plays an important role in regulating DC, macrophages, T cells, NK cells and so on in the microenvironment of tumors. Moreover, exosome can help tumor cells escape the recognition of immune cells by promoting the functions of immunosuppressive cells, such as MDSC and Treg. This review will summarize the role of exosome and its key mediators in mediating tumor immune escape and immune tolerance, and review the latest progress in this field.
尹春来,赵雪梅,侯召华,张建,韩秋菊.外泌体在肿瘤免疫逃逸和耐受中的作用[J].生物化学与生物物理进展,2019,46(5):433-440
复制生物化学与生物物理进展 ® 2025 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号